BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31346607)

  • 1. Inosine RNA modifications are enriched at the codon wobble position in mouse oocytes and eggs†.
    Brachova P; Alvarez NS; Hong X; Gunewardena S; Vincent KA; Latham KE; Christenson LK
    Biol Reprod; 2019 Nov; 101(5):938-949. PubMed ID: 31346607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of
    Brachova P; Alvarez NS; Christenson LK
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine in Biology and Disease.
    Srinivasan S; Torres AG; Ribas de Pouplana L
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33921764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAR-mediated RNA editing in non-coding RNA sequences.
    Yang Y; Zhou X; Jin Y
    Sci China Life Sci; 2013 Oct; 56(10):944-52. PubMed ID: 24008387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using mouse models to unlock the secrets of non-synonymous RNA editing.
    Jinnah H; Ulbricht RJ
    Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine induces context-dependent recoding and translational stalling.
    Licht K; Hartl M; Amman F; Anrather D; Janisiw MP; Jantsch MF
    Nucleic Acids Res; 2019 Jan; 47(1):3-14. PubMed ID: 30462291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening for functional adenosine to inosine RNA editing systems.
    Pokharel S; Beal PA
    ACS Chem Biol; 2006 Dec; 1(12):761-5. PubMed ID: 17240974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and rescue of a tRNA wobble inosine deficiency causing intellectual disability disorder.
    Ramos J; Proven M; Halvardson J; Hagelskamp F; Kuchinskaya E; Phelan B; Bell R; Kellner SM; Feuk L; Thuresson AC; Fu D
    RNA; 2020 Nov; 26(11):1654-1666. PubMed ID: 32763916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-to-I RNA editing and cancer: from pathology to basic science.
    Gallo A; Galardi S
    RNA Biol; 2008; 5(3):135-9. PubMed ID: 18758244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laminin chain-specific gene expression during mouse oocyte maturation.
    Shim C; Lee SG; Song WK; Lee CS; Lee KK; Kim K
    Mol Reprod Dev; 1997 Oct; 48(2):185-93. PubMed ID: 9291468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epitranscriptome and Innate Immunity.
    O'Connell MA; Mannion NM; Keegan LP
    PLoS Genet; 2015 Dec; 11(12):e1005687. PubMed ID: 26658668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transcriptional and post-translational regulation during mouse oocyte maturation.
    Kang MK; Han SJ
    BMB Rep; 2011 Mar; 44(3):147-57. PubMed ID: 21429291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where have all the inosines gone? Conflicting evidence for A-to-I editing of the anticodon of higher eukaryotic tRNAACGArg questions the dogma of a universal wobble-mediated decoding of CGN codons.
    Igloi GL; Aldinger CA
    IUBMB Life; 2016 Jun; 68(6):419-22. PubMed ID: 27029281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis of rhesus monkey failed-to-mature oocytes: deficiencies in transcriptional regulation and cytoplasmic maturation of the oocyte mRNA population.
    Ruebel ML; Schall PZ; Midic U; Vincent KA; Goheen B; VandeVoort CA; Latham KE
    Mol Hum Reprod; 2018 Oct; 24(10):478-494. PubMed ID: 30085220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
    Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
    Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAR-related activation of adenosine-to-inosine RNA editing during regeneration.
    Witman NM; Behm M; Ohman M; Morrison JI
    Stem Cells Dev; 2013 Aug; 22(16):2254-67. PubMed ID: 23534823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
    Deffit SN; Hundley HA
    Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics.
    Nakano M; Nakajima M
    Pharmacol Ther; 2018 Jan; 181():13-21. PubMed ID: 28716651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.